December 29, 2014 3:37 AM ET

Capital Markets

Company Overview of Tekla Life Sciences Investors

Executive Profile

Daniel R. Omstead Ph.D.

Chief Executive Officer, President, Trustee, Member of Valuation Committee, Chief Executive Officer of Hambrecht & Quist Capital Management LLC, President - HQL , President of Hambrecht & Quist Capital Management LLC and Trustee of HQL , Tekla Healthcare Investors
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 8 different industries.

See Board Relationships
61--

Background

Dr. Daniel R. Omstead, also known as Dan, PhD, serves as President, Chief Executive Officer, Chief Financial Officer, Manager and a Portfolio Manger of Tekla Capital Management LLC (formerly, Hambrecht & Quist Capital Management LLC), the Adviser of H&Q Healthcare Investors. Mr. Omstead has been President and Portfolio Manager at Tekla Life Sciences Investors (alternate name: H&Q Life sciences Investors) and H&Q Healthcare Investors since 2001. He has been President ...

Corporate Headquarters

2 Liberty Square
Boston, Massachusetts 02109

United States

Phone: 617-772-8500
Fax: 617-772-8577

Board Members Memberships

Director
Former Director
Director
Director
2003-Present
Principal Executive Officer, President, Trustee and Member of Valuation Committee
2003-Present
Chief Executive Officer, President, Trustee, Member of Valuation Committee, Chief Executive Officer of Hambrecht & Quist Capital Management LLC, President - HQL , President of Hambrecht & Quist Capital Management LLC and Trustee of HQL
2008-Present
Director
2008-N/A
Director
2011-N/A
Director
2012-N/A
Former Director
2014-Present
President and Trustee

Education

PhD
Columbia University
Master's Degree
Columbia University
BS
Lehigh University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Tekla Life Sciences Investors, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.